The Jomed Covered Stent Graft for coronary artery aneurysms and acute perforation: a successful device which needs careful deployment and may not reduce restenosis

J Invasive Cardiol. 2000 May;12(5):272-6.


The Jomed Covered Stent Graft (Jomed International AB, Helsingborg, Sweden) is marketed for treatment of coronary artery aneurysms, perforations, dissection or thrombus. Three cases are presented, two with aneurysms, one with an acute coronary perforation. Intravascular ultrasound (IVUS) identified the need for high-pressure deployment of the stent. Although it has been suggested that this stent might lead to reduced rates of restenosis, one case later developed proliferative and occlusive in-stent restenosis and another suffered stent thrombosis at one month shortly after discontinuing clopidogrel. This niche stent clearly has an important role, but high-pressure deployment, IVUS evaluation and prolonged antiplatelet therapy are strongly recommended.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Aneurysm, Ruptured / diagnostic imaging
  • Aneurysm, Ruptured / surgery*
  • Animals
  • Blood Vessel Prosthesis Implantation / instrumentation*
  • Blood Vessel Prosthesis Implantation / methods
  • Coated Materials, Biocompatible
  • Coronary Aneurysm / diagnostic imaging
  • Coronary Aneurysm / surgery*
  • Coronary Angiography
  • Coronary Disease / prevention & control
  • Coronary Disease / therapy
  • Cricetinae
  • Female
  • Follow-Up Studies
  • Graft Survival
  • Humans
  • Male
  • Middle Aged
  • Polytetrafluoroethylene*
  • Secondary Prevention
  • Sensitivity and Specificity
  • Stents*
  • Ultrasonography, Interventional


  • Coated Materials, Biocompatible
  • Polytetrafluoroethylene